The aim of this study was mainly to assess the clinical utility of TP53 mutation and MET amplification in ctDNA as biomarkers for monitoring disease progression of AGC.
| Accession | PRJNA667505 |
| Data Type | Raw sequence reads |
| Scope | Multispecies |
| Submission | Registration date: 5-Oct-2020
Longhua Hospital, Shanghai University of Traditional Chinese Medicine (TCM) |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 20 |
| Other datasets |
| BioSample | 20 |